title: Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients' value.
authors.affiliation: Prof. Lars Wallentin, MD, Uppsala University, Uppsala Clinical Research Centre and Department of Medical Sciences, Cardiology, Uppsala, Uppland, Sweden, E-mail: Lars.Wallentin@ucr.uu.se.
authors.forename: L
authors.initials: L
authors.lastname: Wallentin
authors.forename: A
authors.initials: A
authors.lastname: Himmelmann
authors.forename: R F
authors.initials: RF
authors.lastname: Storey
authors.forename: P G
authors.initials: PG
authors.lastname: Steg
authors.forename: R A
authors.initials: RA
authors.lastname: Harrington
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000191:economics; D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D003365:Costs and Cost Analysis; D004363:Drug Utilization; D019317:Evidence-Based Medicine; D006801:Humans; D007391:International Cooperation; D040541:Marketing; D017060:Patient Satisfaction; D010879:Piperazines / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D000068799:Prasugrel Hydrochloride; D013876:Thiophenes / Q000627:therapeutic use*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine